Sorin Group
Sorin, MicroPort land Chinese approval for joint CRM venture
Sorin wins FDA approval for Mitroflow heart valve plus calcification reduction
Sorin Group (BIT:SRN) won FDA approval for a the next generation of its Mitroflow bioprosthetic valves, touting new features that improve the implant’s durability be reducing calcification.
March 2014 Medical device recalls | Medtech regulatory news for the week of Apr. 7, 2014
Medical device recalls for March 2014
April 2, 2014 by MassDevice staff
March Summary
Class I recalls: 10
Class II recalls: 183
Sorin wins expanded CE Mark for Perceval aortic valve
Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for adult patients to be treated with its Perceval sutureless aortic valve.
Sorin drops $20M on Oscor’s cardiac lead biz
Sorin Group (BIT:SRN) said it agreed to put $20 million down on Oscor’s cardiac lead manufacturing business as it gears up to develop MRI-safe leads.
Sorin’s Q4, 2013 profits soar
Sorin Group (BIT:SRN) said its profits surged during the 4th quarter and 2013, saying it’s successfully recovered from a pair of earthquake in Italy that damaged 1 of its plants.
Sorin nabs cardiac cannulae from supplier Bioengineering Labs
Sorin Group (BIT:SRN) took over manufacturing for a unit of cardiac surgical cannulae, buying the business from supplier Bioengineering Laboratories S.p.A. for an undisclosed amount.
Sorin, MicroPort ink China JV
Sorin wins CE Mark for Intensia defibrillators
Sorin Group (BIT:SRN) said its Intensia line of implantable cardioverter defibrillators and cardiac resynchronization therapy devices won CE Mark approval in the European Union.
Sorin lands CE Mark for MRI-compatible pacemaker
Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for its Kora 100 DR and SR pacemakers.